MBL expression in patients with recurrent tonsillitis

Domenico Leonardo Grasso, Ludovica Segat, Elisabetta Zocconi, Oriano Radillo, Chiara Trevisiol, Sergio Crovella

Research output: Contribution to journalArticle

Abstract

Objective: We evaluated mannose binding lectin (MBL) protein production and histological localization, MBL2 gene expression and genotypes distribution in patients characterized by recurrent tonsillitis, with the aim of verifying the innate immune response to the infection and inflammation occurring in the tonsils. Methods: MBL2 exon 1 and promoter polymorphims were detected by PCR amplification and subsequent direct sequencing of the amplicons. Monoclonal antibodies to MBL were used on frozen sections of tonsils for the immunohistochemical localization of MBL protein. MBL Oligomer ELISA kit was used to quantify the level of MBL in the serum of the 30 patients with recurrent tonsillitis. Quantitative RT PCR for the evaluation of MBL2 expression of MBL high producers (HP), low producers (LP) and deficient producers (DP) was performed using the Hs00175093 gene-expression Assay on Demand. Results: The distribution of the MBL2 combined genotypes was as follows: 21 HP (70%; 15 HYA/HYA, 6 HYA/LXA), 6 LP (20%; 5 HYA/0, 1 LXA/LXA) and 3 DP (10%, all 0/0). MBL levels were directly correlated to the MBL2 combined genotypes: HP patients showed higher mean MBL concentration of 4044 ng/mL, LP patients were characterized by a mean of 905 ng/mL whereas those with DP combined genotype presented extremely low levels of MBL (mean value of 74 ng/mL) (p = 0.0005). Immunohistochemistry performed on tonsils sections demonstrated that MBL was widely distributed throughout the surface of the basal lamina of all the 21 HP subjects. MBL was undetectable in situ in both LP and DP patients. MBL2 expression, although at very low levels, was found for the HP group, the LP and the DP group as well. Conclusions: We confirmed the genotype-phenotype correlation of MBL2 gene exon 1 and promoter polymorphisms with the quantitative production of serum MBL, we reported a very low MBL2 expression at local level in tonsils and we determined the in situ localization of MBL in the basal lamina of the tonsils of patients who underwent to tonsillectomy. Our findings suggest an important role of MBL protein in the innate immune response of the tonsil to pathogens, as in recurrent infection and inflammation.

Original languageEnglish
Pages (from-to)1550-1553
Number of pages4
JournalInternational Journal of Pediatric Otorhinolaryngology
Volume73
Issue number11
DOIs
Publication statusPublished - Nov 2009

Fingerprint

Mannose-Binding Lectin
Tonsillitis
Palatine Tonsil
Genotype
Basement Membrane
Innate Immunity
Exons
Inflammation
Gene Expression
Polymerase Chain Reaction
Proteins
Tonsillectomy
Frozen Sections
Genetic Association Studies
Infection
Serum

Keywords

  • ELISA
  • Gene expression
  • Genetic polymorphisms
  • Immunohistochemistry
  • Innate immunity
  • MBL
  • Recurrent tonsillitis

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Pediatrics, Perinatology, and Child Health

Cite this

MBL expression in patients with recurrent tonsillitis. / Grasso, Domenico Leonardo; Segat, Ludovica; Zocconi, Elisabetta; Radillo, Oriano; Trevisiol, Chiara; Crovella, Sergio.

In: International Journal of Pediatric Otorhinolaryngology, Vol. 73, No. 11, 11.2009, p. 1550-1553.

Research output: Contribution to journalArticle

Grasso, Domenico Leonardo ; Segat, Ludovica ; Zocconi, Elisabetta ; Radillo, Oriano ; Trevisiol, Chiara ; Crovella, Sergio. / MBL expression in patients with recurrent tonsillitis. In: International Journal of Pediatric Otorhinolaryngology. 2009 ; Vol. 73, No. 11. pp. 1550-1553.
@article{1c112e195eb9441faa5fe203f1dec1fb,
title = "MBL expression in patients with recurrent tonsillitis",
abstract = "Objective: We evaluated mannose binding lectin (MBL) protein production and histological localization, MBL2 gene expression and genotypes distribution in patients characterized by recurrent tonsillitis, with the aim of verifying the innate immune response to the infection and inflammation occurring in the tonsils. Methods: MBL2 exon 1 and promoter polymorphims were detected by PCR amplification and subsequent direct sequencing of the amplicons. Monoclonal antibodies to MBL were used on frozen sections of tonsils for the immunohistochemical localization of MBL protein. MBL Oligomer ELISA kit was used to quantify the level of MBL in the serum of the 30 patients with recurrent tonsillitis. Quantitative RT PCR for the evaluation of MBL2 expression of MBL high producers (HP), low producers (LP) and deficient producers (DP) was performed using the Hs00175093 gene-expression Assay on Demand. Results: The distribution of the MBL2 combined genotypes was as follows: 21 HP (70{\%}; 15 HYA/HYA, 6 HYA/LXA), 6 LP (20{\%}; 5 HYA/0, 1 LXA/LXA) and 3 DP (10{\%}, all 0/0). MBL levels were directly correlated to the MBL2 combined genotypes: HP patients showed higher mean MBL concentration of 4044 ng/mL, LP patients were characterized by a mean of 905 ng/mL whereas those with DP combined genotype presented extremely low levels of MBL (mean value of 74 ng/mL) (p = 0.0005). Immunohistochemistry performed on tonsils sections demonstrated that MBL was widely distributed throughout the surface of the basal lamina of all the 21 HP subjects. MBL was undetectable in situ in both LP and DP patients. MBL2 expression, although at very low levels, was found for the HP group, the LP and the DP group as well. Conclusions: We confirmed the genotype-phenotype correlation of MBL2 gene exon 1 and promoter polymorphisms with the quantitative production of serum MBL, we reported a very low MBL2 expression at local level in tonsils and we determined the in situ localization of MBL in the basal lamina of the tonsils of patients who underwent to tonsillectomy. Our findings suggest an important role of MBL protein in the innate immune response of the tonsil to pathogens, as in recurrent infection and inflammation.",
keywords = "ELISA, Gene expression, Genetic polymorphisms, Immunohistochemistry, Innate immunity, MBL, Recurrent tonsillitis",
author = "Grasso, {Domenico Leonardo} and Ludovica Segat and Elisabetta Zocconi and Oriano Radillo and Chiara Trevisiol and Sergio Crovella",
year = "2009",
month = "11",
doi = "10.1016/j.ijporl.2009.07.022",
language = "English",
volume = "73",
pages = "1550--1553",
journal = "International Journal of Pediatric Otorhinolaryngology",
issn = "0165-5876",
publisher = "Elsevier Ireland Ltd",
number = "11",

}

TY - JOUR

T1 - MBL expression in patients with recurrent tonsillitis

AU - Grasso, Domenico Leonardo

AU - Segat, Ludovica

AU - Zocconi, Elisabetta

AU - Radillo, Oriano

AU - Trevisiol, Chiara

AU - Crovella, Sergio

PY - 2009/11

Y1 - 2009/11

N2 - Objective: We evaluated mannose binding lectin (MBL) protein production and histological localization, MBL2 gene expression and genotypes distribution in patients characterized by recurrent tonsillitis, with the aim of verifying the innate immune response to the infection and inflammation occurring in the tonsils. Methods: MBL2 exon 1 and promoter polymorphims were detected by PCR amplification and subsequent direct sequencing of the amplicons. Monoclonal antibodies to MBL were used on frozen sections of tonsils for the immunohistochemical localization of MBL protein. MBL Oligomer ELISA kit was used to quantify the level of MBL in the serum of the 30 patients with recurrent tonsillitis. Quantitative RT PCR for the evaluation of MBL2 expression of MBL high producers (HP), low producers (LP) and deficient producers (DP) was performed using the Hs00175093 gene-expression Assay on Demand. Results: The distribution of the MBL2 combined genotypes was as follows: 21 HP (70%; 15 HYA/HYA, 6 HYA/LXA), 6 LP (20%; 5 HYA/0, 1 LXA/LXA) and 3 DP (10%, all 0/0). MBL levels were directly correlated to the MBL2 combined genotypes: HP patients showed higher mean MBL concentration of 4044 ng/mL, LP patients were characterized by a mean of 905 ng/mL whereas those with DP combined genotype presented extremely low levels of MBL (mean value of 74 ng/mL) (p = 0.0005). Immunohistochemistry performed on tonsils sections demonstrated that MBL was widely distributed throughout the surface of the basal lamina of all the 21 HP subjects. MBL was undetectable in situ in both LP and DP patients. MBL2 expression, although at very low levels, was found for the HP group, the LP and the DP group as well. Conclusions: We confirmed the genotype-phenotype correlation of MBL2 gene exon 1 and promoter polymorphisms with the quantitative production of serum MBL, we reported a very low MBL2 expression at local level in tonsils and we determined the in situ localization of MBL in the basal lamina of the tonsils of patients who underwent to tonsillectomy. Our findings suggest an important role of MBL protein in the innate immune response of the tonsil to pathogens, as in recurrent infection and inflammation.

AB - Objective: We evaluated mannose binding lectin (MBL) protein production and histological localization, MBL2 gene expression and genotypes distribution in patients characterized by recurrent tonsillitis, with the aim of verifying the innate immune response to the infection and inflammation occurring in the tonsils. Methods: MBL2 exon 1 and promoter polymorphims were detected by PCR amplification and subsequent direct sequencing of the amplicons. Monoclonal antibodies to MBL were used on frozen sections of tonsils for the immunohistochemical localization of MBL protein. MBL Oligomer ELISA kit was used to quantify the level of MBL in the serum of the 30 patients with recurrent tonsillitis. Quantitative RT PCR for the evaluation of MBL2 expression of MBL high producers (HP), low producers (LP) and deficient producers (DP) was performed using the Hs00175093 gene-expression Assay on Demand. Results: The distribution of the MBL2 combined genotypes was as follows: 21 HP (70%; 15 HYA/HYA, 6 HYA/LXA), 6 LP (20%; 5 HYA/0, 1 LXA/LXA) and 3 DP (10%, all 0/0). MBL levels were directly correlated to the MBL2 combined genotypes: HP patients showed higher mean MBL concentration of 4044 ng/mL, LP patients were characterized by a mean of 905 ng/mL whereas those with DP combined genotype presented extremely low levels of MBL (mean value of 74 ng/mL) (p = 0.0005). Immunohistochemistry performed on tonsils sections demonstrated that MBL was widely distributed throughout the surface of the basal lamina of all the 21 HP subjects. MBL was undetectable in situ in both LP and DP patients. MBL2 expression, although at very low levels, was found for the HP group, the LP and the DP group as well. Conclusions: We confirmed the genotype-phenotype correlation of MBL2 gene exon 1 and promoter polymorphisms with the quantitative production of serum MBL, we reported a very low MBL2 expression at local level in tonsils and we determined the in situ localization of MBL in the basal lamina of the tonsils of patients who underwent to tonsillectomy. Our findings suggest an important role of MBL protein in the innate immune response of the tonsil to pathogens, as in recurrent infection and inflammation.

KW - ELISA

KW - Gene expression

KW - Genetic polymorphisms

KW - Immunohistochemistry

KW - Innate immunity

KW - MBL

KW - Recurrent tonsillitis

UR - http://www.scopus.com/inward/record.url?scp=70349627517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349627517&partnerID=8YFLogxK

U2 - 10.1016/j.ijporl.2009.07.022

DO - 10.1016/j.ijporl.2009.07.022

M3 - Article

C2 - 19716183

AN - SCOPUS:70349627517

VL - 73

SP - 1550

EP - 1553

JO - International Journal of Pediatric Otorhinolaryngology

JF - International Journal of Pediatric Otorhinolaryngology

SN - 0165-5876

IS - 11

ER -